Commonwealth Equity Services’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
AFM
Commonwealth Equity Services's SLS Position: Q2 2026 in Review
Commonwealth Equity Services increased its SELLAS Life Sciences (SLS) stake by 17% in Q2 2026, buying an estimated $45.7K and bringing the position to 45,087 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.
Commonwealth Equity Services first reported a position in SLS in Q4 2017 and has held it in 14 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.
- Commonwealth Equity Services held 45,087 shares of SELLAS Life Sciences worth $665K as of Q2 2026.
- Commonwealth Equity Services bought 6,617 SELLAS Life Sciences shares in Q2 2026, an estimated $45.7K.
- SELLAS Life Sciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3064 holding.
- Commonwealth Equity Services first reported a position in SELLAS Life Sciences in Q4 2017 and has held it in 14 quarters since.
- 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.